Genomics in CKD: Is This the Path Forward?
Related Experiment Video
Updated: Jan 31, 2026

Ultra-long Read Sequencing for Whole Genomic DNA Analysis
Published on: March 15, 2019
Girish N Nadkarni1, Carol R Horowitz1
1Department of Medicine, Division of Nephrology, Icahn School of Medicine, New York, NY; Department of Population Health Science and Policy, Icahn School of Medicine, New York, NY; and Department of Medicine, Icahn School of Medicine, New York, NY.
Abstract:
Recent advances in genomics and sequencing technology have led to a better understanding of genetic risk in CKD. Genetics could account in part for racial differences in treatment response for medications including antihypertensives and immunosuppressive medications due to its correlation with ancestry. However, there is still a substantial lag between generation of this knowledge and its adoption in routine clinical care. This review summarizes the recent advances in genomics and CKD, discusses potential reasons for its underutilization, and highlights potential avenues for application of genomic information to improve clinical care and outcomes in this particularly vulnerable population.
Related Concept Videos
Mean free path and Mean free time
Path Between Thermodynamics States
Genomics
Interference: Path Lengths
Two special sources may be considered when they are in phase. This can be easily achieved by feeding the two sources from the same source. An example would be synchronizing the two speakers by feeding them with the same source, such as the sound waves produced by a tuning fork. This setup ensures that the two sources have the same frequency and are...
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

